Advani, A. and Mughal, S.A. (2025) “Luspatercept (REBLOZYL): A Game-Changer in Reducing Transfusion Burden for β-Thalassemia Patients”, Innovative Research in Applied, Biological and Chemical Sciences, 3(1). doi:10.62497/irabcs.150.